Current surveillance strategy is less effective for detecting early-stage hepatocellular carcinoma in patients with non-viral and non-cirrhotic liver disease
(2025)
Journal Article
Spiers, J., Li, W., Aravinthan, A. D., Bannaga, A., Caddick, K., Culver, E. L., Faulkes, R. E., Gordon, V., Hussain, Y., Miller, H., Merry, J., Saad, M., Sheth, A., Shah, T., Shetty, S., Srivastava, A., Subhani, M., Tahir, M. N., Than, N. N., Unitt, E., & Alazawi, W. (2025). Current surveillance strategy is less effective for detecting early-stage hepatocellular carcinoma in patients with non-viral and non-cirrhotic liver disease. Liver Cancer, https://doi.org/10.1159/000542805
Introduction
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths. Current international guidelines recommend 6-monthly ultrasound surveillance in all patients with cirrhosis and those with hepatitis B virus-related risk facto...
Read More about Current surveillance strategy is less effective for detecting early-stage hepatocellular carcinoma in patients with non-viral and non-cirrhotic liver disease.